Best for
Mobile

Posted
Diaceutics PLC is a biotechnology business based in the UK. Diaceutics shares (DXRX.LSE) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. Its last market close was 130p – a decrease of 3.35% over the previous week. Diaceutics employs 128 staff and has a trailing 12-month revenue of around £14.4 million.
Best for
Mobile
Best for
Low-cost
Best for
All rounder
Best for
Beginners
Since the stock market crash in March caused by coronavirus, Diaceutics's share price has had significant negative movement.
Its last market close was 130p, which is 14.19% down on its pre-crash value of 151.5p and 22.36% up on the lowest point reached during the March crash when the shares fell as low as 106.24p.
If you had bought £1,000 worth of Diaceutics shares at the start of February 2020, those shares would have been worth £957.85 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £996.16.
Latest market close | 130p |
---|---|
52-week range | 101.6p - 195p |
50-day moving average | 131.0294p |
200-day moving average | 144.7641p |
PE ratio | 25.2222 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | 4.5p |
Other fees may apply. Your capital is at risk.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of 130p
1 week (2021-01-13) | -14.47% |
---|---|
1 month (2020-12-23) | 12.55% |
3 months (2020-10-23) | 8.11% |
6 months (2020-07-21) | -21.21% |
1 year (2020-01-21) | 10.64% |
---|
Valuing Diaceutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Diaceutics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Diaceutics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 25x. In other words, Diaceutics shares trade at around 25x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Diaceutics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £2.8 million.
The EBITDA is a measure of a Diaceutics's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | £14.4 million |
---|---|
Operating margin TTM | 17.08% |
Gross profit TTM | £10.3 million |
Return on assets TTM | 4.9% |
Return on equity TTM | 10.83% |
Profit margin | 22.32% |
Book value | 0.489p |
Market capitalisation | £95.4 million |
TTM: trailing 12 months
We're not expecting Diaceutics to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Subscribe to trending stock alerts for a chance to win
Diaceutics Plc provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It offers diagnostic landscape services, such as patient journey, lab mapping, diagnostic regulation, turnaround time, and sample availability analysis services; diagnostic tracking services, including lab tracking, patient insights, and physician segmentation services; and diagnostic payers research, diagnostic clinical landscape, integrated mapping research, buying process research, and testers/non-testers research services. The company also provides diagnostic planning services consisting of strategic and tactical planning, launch planning, diagnostic partner selection, and financial forecast services; commercialization services comprising content creation; LabEd/workshops, diagnostic adboards, conference support, and proficiency testing services; and Diagnostic reimbursement services. Diaceutics Plc was founded in 2005 and is headquartered in Belfast, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.